By activating both GLP-1 and GIP receptors, Tirzepatide helps regulate blood sugar levels and promotes weight loss
Some batches might be closer to the claimed purity
[12] [13] The antihypertensive effects of thiazides may be enhanced in other patients predisposed for orthostatic hypotension, including the post-sympathectomy patient
Long-term use safety Traditional pain meds: Not safe for years of continuous use Require breaks or rotation Accumulating damage to organs Peptides: Can use for months to years safely BPC-157 and TB-500 have decades of use data No cumulative toxicity Actually heal tissue rather than damage it Combining peptides with pain medications Can use together: Peptides for healing NSAIDs for acute breakthrough pain Reduce medication dose as peptides work Transition plan: Start peptides while on pain meds As pain improves, reduce medication slowly Goal: Minimal or no pain meds long-term See our peptide safety and risks guide
Due to its stimulant nature, Vyvanse has the potential for misuse, leading to dependence or addiction
In practice the GLP-1 and GIP parts win the tug-of-war, so blood sugar control gets better with retatrutide, not worse
